These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30302950)
1. Supramolecular Nanofibers of Drug-Peptide Amphiphile and Affibody Suppress HER2+ Tumor Growth. Liang C; Zhang L; Zhao W; Xu L; Chen Y; Long J; Wang F; Wang L; Yang Z Adv Healthc Mater; 2018 Nov; 7(22):e1800899. PubMed ID: 30302950 [TBL] [Abstract][Full Text] [Related]
2. Nanospheres of doxorubicin as cross-linkers for a supramolecular hydrogelation. Xue Q; Ren H; Xu C; Wang G; Ren C; Hao J; Ding D Sci Rep; 2015 Mar; 5():8764. PubMed ID: 25739554 [TBL] [Abstract][Full Text] [Related]
3. Enzyme-Instructed Self-Assembly (EISA) and Hydrogelation of Peptides. Gao J; Zhan J; Yang Z Adv Mater; 2020 Jan; 32(3):e1805798. PubMed ID: 31018025 [TBL] [Abstract][Full Text] [Related]
4. pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy. Liang P; Zheng J; Dai S; Wang J; Zhang Z; Kang T; Quan C J Control Release; 2017 Aug; 260():22-31. PubMed ID: 28522193 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-instructed self-assembly of peptide derivatives to form nanofibers and hydrogels. Gao Y; Yang Z; Kuang Y; Ma ML; Li J; Zhao F; Xu B Biopolymers; 2010; 94(1):19-31. PubMed ID: 20091873 [TBL] [Abstract][Full Text] [Related]
6. Biocompatible fluorescent supramolecular nanofibrous hydrogel for long-term cell tracking and tumor imaging applications. Wang H; Mao D; Wang Y; Wang K; Yi X; Kong D; Yang Z; Liu Q; Ding D Sci Rep; 2015 Nov; 5():16680. PubMed ID: 26573372 [TBL] [Abstract][Full Text] [Related]
7. Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors. Altai M; Liu H; Ding H; Mitran B; Edqvist PH; Tolmachev V; Orlova A; Gräslund T J Control Release; 2018 Oct; 288():84-95. PubMed ID: 30172673 [TBL] [Abstract][Full Text] [Related]
8. Magnetism and photo dual-controlled supramolecular assembly for suppression of tumor invasion and metastasis. Yu Q; Zhang YM; Liu YH; Xu X; Liu Y Sci Adv; 2018 Sep; 4(9):eaat2297. PubMed ID: 30255143 [TBL] [Abstract][Full Text] [Related]
9. A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells. Berns EJ; Álvarez Z; Goldberger JE; Boekhoven J; Kessler JA; Kuhn HG; Stupp SI Acta Biomater; 2016 Jun; 37():50-8. PubMed ID: 27063496 [TBL] [Abstract][Full Text] [Related]
10. Intramolecular interactions of a phenyl/perfluorophenyl pair in the formation of supramolecular nanofibers and hydrogels. Hsu SM; Lin YC; Chang JW; Liu YH; Lin HC Angew Chem Int Ed Engl; 2014 Feb; 53(7):1921-7. PubMed ID: 24420005 [TBL] [Abstract][Full Text] [Related]
11. Supramolecular nanofibrils inhibit cancer progression in vitro and in vivo. Kuang Y; Du X; Zhou J; Xu B Adv Healthc Mater; 2014 Aug; 3(8):1217-21. PubMed ID: 24574174 [TBL] [Abstract][Full Text] [Related]
12. In Situ Formation of Nanofibers from Purpurin18-Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites. Zhang D; Qi GB; Zhao YX; Qiao SL; Yang C; Wang H Adv Mater; 2015 Oct; 27(40):6125-30. PubMed ID: 26350172 [TBL] [Abstract][Full Text] [Related]
13. An enzyme-assisted self-delivery system of lonidamine-peptide conjugates for selectively killing cancer cells. Wu C; Liu J; Tang X; Zhai Z; Xu K; Zhong W Chem Commun (Camb); 2019 Dec; 55(98):14852-14855. PubMed ID: 31769450 [TBL] [Abstract][Full Text] [Related]
15. Imaging-Based Study on Control Factors over Self-Sorting of Supramolecular Nanofibers Formed from Peptide- and Lipid-type Hydrogelators. Kubota R; Liu S; Shigemitsu H; Nakamura K; Tanaka W; Ikeda M; Hamachi I Bioconjug Chem; 2018 Jun; 29(6):2058-2067. PubMed ID: 29742348 [TBL] [Abstract][Full Text] [Related]
16. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity. Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319 [TBL] [Abstract][Full Text] [Related]
17. A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy. Xia X; Yang X; Gao W; Huang W; Xia X; Yan D J Nanobiotechnology; 2024 Aug; 22(1):502. PubMed ID: 39169343 [TBL] [Abstract][Full Text] [Related]
18. Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules. Perols A; Honarvar H; Strand J; Selvaraju R; Orlova A; Karlström AE; Tolmachev V Bioconjug Chem; 2012 Aug; 23(8):1661-70. PubMed ID: 22768790 [TBL] [Abstract][Full Text] [Related]
19. pH and amphiphilic structure direct supramolecular behavior in biofunctional assemblies. Moyer TJ; Finbloom JA; Chen F; Toft DJ; Cryns VL; Stupp SI J Am Chem Soc; 2014 Oct; 136(42):14746-52. PubMed ID: 25310840 [TBL] [Abstract][Full Text] [Related]